Enzymatic Peptide Remodeling for Glycosylation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant peptides as therapeutic agents face challenges in achieving the correct glycosylation pattern, leading to issues such as immunogenicity, suboptimal potency, and rapid clearance, with existing techniques lacking a scalable and industrially practical approach for customizing glycosylation patterns and incorporating modifying groups like PEG for improved properties.
Innovation Solution
A cell-free, in vitro method involving glycosyltransferases and glycosidases to remodel peptides by removing specific saccharide subunits and adding modifying groups like poly(ethylene glycol) (PEG) to achieve desired glycosylation structures, allowing for the production of peptides with enhanced therapeutic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If recombinant peptides are produced using conventional methods, then production scalability is achieved, but the glycosylation pattern is incorrect leading to immunogenicity and rapid clearance
Solution Approach 1:
The glycosylation process is segmented into distinct enzymatic steps: first removing incorrect glycans with glycosidases, then adding correct glycans with glycosyltransferases in a controlled sequence. This segmentation allows each enzymatic reaction to be optimized independently, ensuring correct glycosylation patterns while maintaining scalability through modular process design.
Solution Approach 2:
Enzymes (glycosidases and glycosyltransferases) serve as intermediaries that mediate the glycosylation process. These biological catalysts enable precise control over glycan structure and composition, producing therapeutically correct glycosylation patterns while the cell-free system maintains manufacturing scalability.
2Stability of the object's composition
If glycosylation patterns are customized to improve therapeutic efficacy, then peptide stability and half-life are improved, but production complexity increases
Solution Approach 1:
The production method controls glycosylation by changing enzymatic parameters: selecting specific glycosidases and glycosyltransferases, controlling enzyme concentrations, reaction times, and temperatures. This allows customization of glycan structures (affecting stability and half-life) while keeping the overall process relatively simple through well-defined parameter control rather than complex process architecture.
3Duration of action of stationary object
If terminal sialic acid residues are added to glycans, then peptide half-life in circulation is extended, but the manufacturing process becomes more difficult
Solution Approach 1:
The methodology prepares the glycan structure in advance by first installing the core glycan and terminal sugars (galactose, N-acetylglucosamine) before adding sialic acid residues. This preliminary preparation creates the correct substrate structure that enables efficient sialylation in a subsequent step, extending half-life while maintaining manufacturing ease through staged preparation.
4Object-affected harmful factors
If PEG groups are incorporated into the peptide structure, then immunogenicity is reduced and therapeutic properties are enhanced, but the manufacturing process becomes more complex
Solution Approach 1:
The PEG modification process extracts the peptide from the complex cellular environment and performs modification in a simplified cell-free system. This separation allows PEG groups to be incorporated through controlled enzymatic reactions without the complexity of maintaining cellular viability, reducing immunogenicity while keeping manufacturing relatively simple through in vitro processing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of peptides with tailored glycosylation patterns and the incorporation of modifying groups, improving their therapeutic efficacy, immunogenicity, and stability, addressing the limitations of existing techniques by providing a scalable and industrially practical solution.
Implementation Method 1
contacting the truncated glycan with at least one glycosyltransferase and at least one glycosyl donor under conditions suitable to transfer the at least one glycosyl donor to the truncated glycan
Implementation Method 2
removing X2 or a saccharyl subunit thereof from the peptide
Data Source
AI summary
The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group a peptide.